Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathon B Cohen

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Oncology (Williston Park, N.Y.)|June 26, 2018
How to Decide Which DLBCL Patients Should Receive CNS ProphylaxisKevin H Hall, Elyse Hall Panjic, Kelly Valla, et al.
International Journal of Retina and Vitreous|October 12, 2021
Diagnostic retinal biopsy in the management of secondary non-CNS vitreoretinal lymphoma masquerading as viral retinitis: a case reportAditya Rali, Lucy T Xu, Caroline Craven, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 29, 2019
Racial and Socioeconomic Disparities in Mantle Cell LymphomaNikesh N Shah, Yizhao Xi, Yuan Liu, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 24, 2014
Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithmsJay A Read, Jean L Koff, Loretta J Nastoupil, et al.
Journal of Translational Medicine|April 28, 2016
GIFT4 fusokine converts leukemic B cells into immune helper cellsJiusheng Deng, Andrea Pennati, Jonathon B Cohen, et al.
Leukemia & Lymphoma|February 24, 2026
Real-world treatment patterns, patient characteristics, and outcomes of initial cBTKi-based therapies in second-line or later amongst a contemporary cohort of patients with MCL in the United StatesKami Maddocks, Marsha Tracey, Katherine B Winfree, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 28, 2026
An Evaluation of Ibrutinib and Ixazomib in Patients With Relapsed/Refractory Mantle Cell Lymphoma: PrE0404Jonathon B Cohen, Craig A Portell, Mehdi Hamadani, et al.
Leukemia & Lymphoma|August 12, 2017
Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utilityDaniel M Guidot, Jeffrey M Switchenko, Loretta J Nastoupil, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 30, 2022
Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I TrialJason T Romancik, Zhengjia Chen, Pamela B Allen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2016
Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older PatientsTimothy S Fenske, Mehdi Hamadani, Jonathon B Cohen, et al.
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Oncology (Williston Park, N.Y.)|June 26, 2018
How to Decide Which DLBCL Patients Should Receive CNS ProphylaxisKevin H Hall, Elyse Hall Panjic, Kelly Valla, et al.
International Journal of Retina and Vitreous|October 12, 2021
Diagnostic retinal biopsy in the management of secondary non-CNS vitreoretinal lymphoma masquerading as viral retinitis: a case reportAditya Rali, Lucy T Xu, Caroline Craven, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 29, 2019
Racial and Socioeconomic Disparities in Mantle Cell LymphomaNikesh N Shah, Yizhao Xi, Yuan Liu, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 24, 2014
Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithmsJay A Read, Jean L Koff, Loretta J Nastoupil, et al.
Journal of Translational Medicine|April 28, 2016
GIFT4 fusokine converts leukemic B cells into immune helper cellsJiusheng Deng, Andrea Pennati, Jonathon B Cohen, et al.
Leukemia & Lymphoma|February 24, 2026
Real-world treatment patterns, patient characteristics, and outcomes of initial cBTKi-based therapies in second-line or later amongst a contemporary cohort of patients with MCL in the United StatesKami Maddocks, Marsha Tracey, Katherine B Winfree, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 28, 2026
An Evaluation of Ibrutinib and Ixazomib in Patients With Relapsed/Refractory Mantle Cell Lymphoma: PrE0404Jonathon B Cohen, Craig A Portell, Mehdi Hamadani, et al.
Leukemia & Lymphoma|August 12, 2017
Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utilityDaniel M Guidot, Jeffrey M Switchenko, Loretta J Nastoupil, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 30, 2022
Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I TrialJason T Romancik, Zhengjia Chen, Pamela B Allen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2016
Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older PatientsTimothy S Fenske, Mehdi Hamadani, Jonathon B Cohen, et al.
Pageof 13